Thus, an approach to treat AD is the use of AChE inhibitors [115], which reduce the breakdown of endogenously released ACh, increasing ACh levels in the synaptic cleft and amplifying the activation of postsynaptic cholinergic receptors [116]. Here, ACHE is linked to Alzheimer disease.